Abstract
Presently, azoles have emerged as excellent antifungal agents. Their broad-spectrum activity and ability to treat superficial as well as invasive infections have gained them incredible repute in antimicrobial therapy. Azoles inhibit the synthesis of ergosterol in fungi, which is important for maintaining the cell wall. This review briefly portrays the relevance of azoles in treating cancer linked fungal infections like candidiasis and aspergillosis. First generation azoles like itraconazole and fluconazole are preferred over other drugs like amphotericin B. Newer azoles (triazoles like voriconazole, posaconazole and ravuconazole) have been synthesized to oust the earlier varieties by being more potent and active against resistant organisms. Patients with lymphoma or leukemia undergoing chemotherapy or stem cell transplantation have weak immune status which makes them susceptible hosts of fungal infections. Azoles are used currently for antitumor therapy because of their specificity towards human cytochrome P-450 dependent enzymes which synthesize cholesterol. This review also attempts to point out how their applications in prostate cancer and breast cancer therapy are indispensable. But along with its advantages, it is necessary to look into the sinister role it plays in creating toxic side effects for patients. Disruption of the endocrine functioning and hepatotoxicity result in manifestations like vomiting, nausea and fatigue. Even though these complications are reversible, the full-fledged practicability of these drugs in cancer treatment is yet to be considered.
Keywords: Aromatase, Aspergillosis, Candidiasis, cancer, lanosterol-14α-demethylase, toxicity, triazoles.
The Natural Products Journal
Title:Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity
Volume: 4 Issue: 2
Author(s): Lesley R. Varughese, Sneha Choubey, Mukesh Yadav and Vikas Beniwal
Affiliation:
Keywords: Aromatase, Aspergillosis, Candidiasis, cancer, lanosterol-14α-demethylase, toxicity, triazoles.
Abstract: Presently, azoles have emerged as excellent antifungal agents. Their broad-spectrum activity and ability to treat superficial as well as invasive infections have gained them incredible repute in antimicrobial therapy. Azoles inhibit the synthesis of ergosterol in fungi, which is important for maintaining the cell wall. This review briefly portrays the relevance of azoles in treating cancer linked fungal infections like candidiasis and aspergillosis. First generation azoles like itraconazole and fluconazole are preferred over other drugs like amphotericin B. Newer azoles (triazoles like voriconazole, posaconazole and ravuconazole) have been synthesized to oust the earlier varieties by being more potent and active against resistant organisms. Patients with lymphoma or leukemia undergoing chemotherapy or stem cell transplantation have weak immune status which makes them susceptible hosts of fungal infections. Azoles are used currently for antitumor therapy because of their specificity towards human cytochrome P-450 dependent enzymes which synthesize cholesterol. This review also attempts to point out how their applications in prostate cancer and breast cancer therapy are indispensable. But along with its advantages, it is necessary to look into the sinister role it plays in creating toxic side effects for patients. Disruption of the endocrine functioning and hepatotoxicity result in manifestations like vomiting, nausea and fatigue. Even though these complications are reversible, the full-fledged practicability of these drugs in cancer treatment is yet to be considered.
Export Options
About this article
Cite this article as:
Varughese R. Lesley, Choubey Sneha, Yadav Mukesh and Beniwal Vikas, Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity, The Natural Products Journal 2014; 4 (2) . https://dx.doi.org/10.2174/221031550402141009100751
DOI https://dx.doi.org/10.2174/221031550402141009100751 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BRCA Unclassified Variants: How Can They be Classified?
Current Women`s Health Reviews Targeting Regulatory T Cells for Anticancer Therapy
Mini-Reviews in Medicinal Chemistry The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function
Inflammation & Allergy - Drug Targets (Discontinued) Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic
Current Medicinal Chemistry Synthesis and Clinical Development of Palbociclib: An Overview
Medicinal Chemistry Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics
Current Respiratory Medicine Reviews Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back
Current Drug Targets - Inflammation & Allergy HIV-1 Vpr: A Closer Look at the Multifunctional Protein from the Structural Perspective
Current HIV Research Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Microfluidic Methods for Non-Viral Gene Delivery
Current Gene Therapy A Systematic Review of the Molecular Mechanisms of Uranium -Induced Reproductive Toxicity
Inflammation & Allergy - Drug Targets (Discontinued) Response Surface Methodology for Optimization of Ultrasound Assisted Extraction of Swertiamarin from Enicostema littorale Blume
Current Bioactive Compounds E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Current Topics in Medicinal Chemistry Editorial
Current Pharmaceutical Biotechnology Regulation of Differentiation of Mesenchymal Stem Cells into Musculoskeletal Cells
Current Stem Cell Research & Therapy Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry